you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Oct 27, 16:00
4659.45 -8.25 (-0.18%)
Volume
AVERAGE VOLUME
5-Day
10,134
10-Day
24,821
30-Day
41,047
10,962
  • Prev. Close

    4667.70

  • Open Price

    4657.00

  • Bid Price (Qty.)

    4665.00 (2)

  • Offer Price (Qty.)

    4675.00 (6)

NSE Live

Oct 27, 15:59
4662.70 -3.50 (-0.08%)
Volume
AVERAGE VOLUME
5-Day
362,897
10-Day
353,761
30-Day
398,639
385,808
  • Prev. Close

    4666.20

  • Open Price

    4655.50

  • Bid Price (Qty.)

    4662.70 (438)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Quarterly Results of Dr Reddys Laboratories (in Rs. Cr.) Jun '21 Mar '21 Dec '20 Sep '20 Jun '20  
Net Sales/Income from operations 3,433.50 3,350.70 3,408.20 3,333.60 3,236.80  
Other Operating Income -- -- -- 12.20 7.60  
Total Income From Operations 3,433.50 3,350.70 3,408.20 3,345.80 3,244.40  
EXPENDITURE  
Consumption of Raw Materials 870.70 816.30 845.30 816.50 788.20  
Purchase of Traded Goods 623.50 326.60 321.10 304.30 300.30  
Increase/Decrease in Stocks -302.50 20.80 -87.70 -135.80 -192.90  
Power & Fuel -- -- -- -- --  
Employees Cost 586.50 545.60 571.50 608.00 545.00  
depreciat 197.10 210.70 212.40 214.20 197.70  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- 936.20 --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,093.40 1,038.50 984.00 -- 875.10  
P/L Before Other Inc. , Int., Excpt. Items & Tax 364.80 392.20 561.60 602.40 731.00  
Other Income 186.20 81.60 62.80 26.60 644.70  
P/L Before Int., Excpt. Items & Tax 551.00 473.80 624.40 629.00 1,375.70  
Interest 6.50 16.90 6.50 9.30 14.00  
P/L Before Exceptional Items & Tax 544.50 456.90 617.90 619.70 1,361.70  
Exceptional Items -- -- -- -- --  
P/L Before Tax 544.50 456.90 617.90 619.70 1,361.70  
Tax 131.10 145.40 174.20 138.70 411.50  
P/L After Tax from Ordinary Activities 413.40 311.50 443.70 481.00 950.20  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 413.40 311.50 443.70 481.00 950.20  
Equity Share Capital 83.20 83.20 83.10 83.10 83.10  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 24.94 18.78 26.74 29.00 57.31  
Diluted EPS 24.87 18.73 26.66 28.92 57.18  
EPS After Extra Ordinary  
Basic EPS. 24.94 18.78 26.74 29.00 57.31  
Diluted EPS. 24.87 18.73 26.66 28.92 57.18  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs